{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:10:10Z","timestamp":1761901810442,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013521","name":"Cosmetic Surgery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","award":["GZ-2016-11612"],"award-info":[{"award-number":["GZ-2016-11612"]}],"id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.msard.2022.103720","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T12:42:06Z","timestamp":1646397726000},"page":"103720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Measurement of prothrombin fragment 1+2 in cerebrospinal fluid to identify thrombin generation in inflammatory central nervous system diseases"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9465-3533","authenticated-orcid":false,"given":"Jan Hendrik","family":"Schaefer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yavor","family":"Yalachkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Friedauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Kirchmayr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Miesbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina J.","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Foerch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin A.","family":"Schaller-Paule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.msard.2022.103720_bib0001","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.0000000000000768","article-title":"Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity","volume":"83","author":"Browne","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2022.103720_bib0002","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.msard.2022.103720_bib0003","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41423-019-0221-5","article-title":"Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE","volume":"16","author":"van Kaer","year":"2019","journal-title":"Cell Mol. Immunol."},{"issue":"7","key":"10.1016\/j.msard.2022.103720_bib0004","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41590-018-0135-x","article-title":"Bar-Or A. Reassessing B cell contributions in multiple sclerosis","volume":"19","author":"Li","year":"2018","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.msard.2022.103720_bib0005","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1093\/brain\/awm236","article-title":"Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?","volume":"130","author":"Marik","year":"2007","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.msard.2022.103720_bib0006","article-title":"Analysis of CSF D-Dimer to Identify Intrathecal Fibrin-Driven Autoimmunity in Patients With Multiple Sclerosis","volume":"9","author":"Schaller-Paule","year":"2022","journal-title":"Neurol.: Neuroimmunol. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.msard.2022.103720_bib0007","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrn.2018.13","article-title":"Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics","volume":"19","author":"Petersen","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"issue":"43","key":"10.1016\/j.msard.2022.103720_bib0008","doi-asserted-by":"crossref","first-page":"10363","DOI":"10.1021\/bi00107a001","article-title":"The coagulation cascade: initiation, maintenance, and regulation","volume":"30","author":"Davie","year":"1991","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.msard.2022.103720_bib0009","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood.V99.3.1053","article-title":"Roles for thrombin and fibrin(ogen) in cytokine\/chemokine production and macrophage adhesion in vivo","volume":"99","author":"Szaba","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.msard.2022.103720_bib0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11011-020-00652-w","article-title":"Thrombin generation and activity in multiple sclerosis","volume":"36","author":"Jordan","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"4","key":"10.1016\/j.msard.2022.103720_bib0011","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0896-6273(91)90060-D","article-title":"Prothrombin mRNA is expressed by cells of the nervous system","volume":"6","author":"Dihanich","year":"1991","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.msard.2022.103720_bib0012","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MBC.0000000000000461","article-title":"D-Dimer and prothrombin fragment 1\u00a0+\u00a02 in urine and plasma in patients with clinically suspected venous thromboembolism","volume":"27","author":"Wexels","year":"2016","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"25","key":"10.1016\/j.msard.2022.103720_bib0013","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.21.7752","article-title":"D-dimer and prothrombin fragment 1\u00a0+\u00a02 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study","volume":"27","author":"Ay","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.msard.2022.103720_bib0014","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jinf.2006.11.016","article-title":"Procoagulant and fibrinolytic activity in cerebrospinal fluid from adults with bacterial meningitis","volume":"54","author":"Weisfelt","year":"2007","journal-title":"J. Infect."},{"issue":"2","key":"10.1016\/j.msard.2022.103720_bib0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.msard.2022.103720_bib0016","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/ana.24807","article-title":"Prothrombin and factor X are elevated in multiple sclerosis patients","volume":"80","author":"G\u00f6bel","year":"2016","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2022.103720_bib0017","article-title":"Thrombin generation correlates with disease duration in multiple sclerosis (MS): Novel insights into the MS-associated prothrombotic state","volume":"3","author":"Parsons","year":"2017","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2022.103720_bib0018","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fneur.2018.00245","article-title":"Coagulation factor XII levels and intrinsic thrombin generation in multiple sclerosis","volume":"9","author":"Ziliotto","year":"2018","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2022.103720_bib0019","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.24078","article-title":"Early detection of thrombin activity in neuroinflammatory disease","volume":"75","author":"Davalos","year":"2014","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2022.103720_bib0020","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1023\/A:1020747716815","article-title":"Prothrombin in normal human cerebrospinal fluid originates from the blood","volume":"23","author":"Lewczuk","year":"1998","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.msard.2022.103720_bib0021","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1590\/0004-282x-anp-2020-0094","article-title":"Blood-cerebrospinal fluid (CSF) barrier dysfunction means reduced CSF flow not barrier leakage - conclusions from CSF protein data","volume":"79","author":"Reiber","year":"2021","journal-title":"Arq. Neuropsiquiatr."},{"issue":"6","key":"10.1016\/j.msard.2022.103720_bib0022","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-0404.1996.tb00052.x","article-title":"Blood-CSF barrier integrity in multiple sclerosis","volume":"94","author":"Liebsch","year":"1996","journal-title":"Acta Neurol. Scand."},{"issue":"5","key":"10.1016\/j.msard.2022.103720_bib0023","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1160\/TH11-10-0719","article-title":"Thrombin inhibition profiles in healthy individuals and thrombophilic patients","volume":"107","author":"R\u00fchl","year":"2012","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.msard.2022.103720_bib0024","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-510X(01)00468-3","article-title":"Plasma thrombin\u2013antithrombin III complex is associated with the severity of experimental autoimmune encephalomyelitis","volume":"185","author":"Inaba","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2022.103720_bib0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2017.08.013","article-title":"Rivaroxaban ameliorates disease course in an animal model of multiple sclerosis","volume":"313","author":"Merker","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.msard.2022.103720_bib0026","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12974-017-0926-2","article-title":"Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis","volume":"14","author":"Stolz","year":"2017","journal-title":"J. Neuroinflamm."},{"issue":"11","key":"10.1016\/j.msard.2022.103720_bib0027","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1177\/1352458519852723","article-title":"Brain fibrinogen deposition plays a key role in MS pathophysiology - Yes","volume":"25","author":"Davalos","year":"2019","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.msard.2022.103720_bib0028","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41590-018-0232-x","article-title":"Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration","volume":"19","author":"Ryu","year":"2018","journal-title":"Nat. Immunol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822002358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822002358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:58:19Z","timestamp":1761901099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822002358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":28,"alternative-id":["S2211034822002358"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.103720","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measurement of prothrombin fragment 1+2 in cerebrospinal fluid to identify thrombin generation in inflammatory central nervous system diseases","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.103720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103720"}}